Ftse Mib
34.617,43
0,60%
DAX
19.436,71
1,13%
S&P 500
5.752,07
0,12%
NASDAQ
18.220,26
0,16%
Bitcoin
65.470,74
0,44%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AtriCure Inc (ATRC) AtriCure Inc (ATRC) Notizie

ATRC

AtriCure (ATRC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATRC
DataOraFonteTitoloSimboloCompagnia
18/09/202414:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATRCAtriCure Inc
27/08/202414:00Business WireAtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ DeviceNASDAQ:ATRCAtriCure Inc
22/08/202418:26Business WireAtriCure bénéficie d'une indication élargie du marquage CE pour les dispositifs AtriClip ® qui permettent de réduire les accidents vasculaires cérébraux chez les patients souffrant de fibrillation auriculaireNASDAQ:ATRCAtriCure Inc
22/08/202418:20Business WireAtriCure erhält eine erweiterte CE-Kennzeichnung für AtriClip®-Geräte zur Reduzierung von Schlaganfällen bei Patienten mit VorhofflimmernNASDAQ:ATRCAtriCure Inc
22/08/202414:00Business WireAtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial FibrillationNASDAQ:ATRCAtriCure Inc
16/08/202402:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ATRCAtriCure Inc
01/08/202417:38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ATRCAtriCure Inc
31/07/202417:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATRCAtriCure Inc
30/07/202422:01Business WireAtriCure Reports Second Quarter 2024 Financial ResultsNASDAQ:ATRCAtriCure Inc
30/07/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATRCAtriCure Inc
29/07/202414:00Business WireAtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth ConferenceNASDAQ:ATRCAtriCure Inc
23/07/202414:00Business WireAtriCure Receives Regulatory Approval to Sell AtriClip® Devices in ChinaNASDAQ:ATRCAtriCure Inc
09/07/202414:00Business WireAtriCure to Announce Second Quarter 2024 Financial ResultsNASDAQ:ATRCAtriCure Inc
31/05/202422:18Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:ATRCAtriCure Inc
15/05/202414:00Business WireAtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceNASDAQ:ATRCAtriCure Inc
01/05/202422:01Business WireAtriCure Reports First Quarter 2024 Financial ResultsNASDAQ:ATRCAtriCure Inc
30/04/202414:00Business WireAtriCure to Participate in the 2024 Bank of America Securities Healthcare ConferenceNASDAQ:ATRCAtriCure Inc
18/04/202414:00Business WireAtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain ManagementNASDAQ:ATRCAtriCure Inc
10/04/202414:00Business WireAtriCure to Announce First Quarter 2024 Financial ResultsNASDAQ:ATRCAtriCure Inc
26/03/202413:00Business WireAtriCure to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ATRCAtriCure Inc
27/02/202414:50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ATRCAtriCure Inc
16/02/202420:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ATRCAtriCure Inc
15/02/202422:01Business WireAtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial ResultsNASDAQ:ATRCAtriCure Inc
25/01/202414:00Business WireAtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology ConferenceNASDAQ:ATRCAtriCure Inc
08/01/202414:43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ATRCAtriCure Inc
08/01/202414:00Business WireAtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024NASDAQ:ATRCAtriCure Inc
04/01/202414:00Business WireAtriCure Appoints Shlomi Nachman to the Board of DirectorsNASDAQ:ATRCAtriCure Inc
20/12/202314:00Business WireAtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ATRCAtriCure Inc
08/12/202322:16Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATRCAtriCure Inc
15/11/202314:00Business WireAtriCure to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ATRCAtriCure Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ATRC

La tua Cronologia

TSXV
EDY
Eddy Smart Home Solutions
UNSW
LYXEETH
LUKSO
TSXV
CPA
Chinapintza Mining Corp.
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network